MedPath

Neighborhoods, Networks, Depression, and HIV Risk

Phase 2
Completed
Conditions
Drug Use
HIV
Depression
Interventions
Behavioral: Workshop control
Behavioral: Workshop
Registration Number
NCT01380613
Lead Sponsor
Johns Hopkins Bloomberg School of Public Health
Brief Summary

The goal of this study is to examine how social networks, neighborhood, and depression are related to HIV risk. The intervention is designed to train individuals to cope with feelings of depression or stress as a way to reduce their risk for HIV.

Detailed Description

This study included implementation and evaluation of a small group, randomized controlled, phase II intervention to reduce depressive symptoms and HIV risk behaviors among inner city drug users. The intervention included elements of cognitive behavioral therapy (CBT) for depression among impoverished individuals, emphasizing depressive cognitions and behaviors theorized to be associated with depression and with HIV risk behaviors among mildly to moderately depressed drug users. In addition, the study examined active drug users' social and environmental pathways to depression and subsequent HIV risk behaviors. Specifically, we will hypothesized mediating/moderating effects of neighborhood characteristics, social network factors, and individual level factors on depressive symptoms and HIV risk behaviors.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
965
Inclusion Criteria
  1. 18-55 years old
  2. HIV Risk Behavior:

3a. Injected drugs more than 3 times in the past week OR

3b. Snorted/sniffed heroin or cocaine or smoked crack in the past 6 months AND had 1 of the following sex risks in the past 6 months: i) 2 or more sex partners ii) Had a sex partner who injected drugs iii)Had a sex partner who smoked crack iv) Had a sex partner who was HIV+

  1. Willingness to attend group sessions
Exclusion Criteria
  1. Enrolled in another HIV behavioral intervention or depression study in past the 3 years
  2. Enrolled in another Lighthouse study in past the 5 years
  3. Enrolled in the formative research (Phase 1) or pilot (Phase 2) of the current project.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Workshop ControlWorkshop controlParticipants receive HIV/STDs risk reduction information.
Intervention WorkshopWorkshopParticipants learn skills to cope with depressive symptoms and stress as well as safer sex and injection skills.
Primary Outcome Measures
NameTimeMethod
Change from Baseline in Depressive Symptoms Measured by the CESD Scale at 12 months12 months
Change from Baseline in Depressive Symptoms Measured by the CESD Scale at 6 months6 months
Secondary Outcome Measures
NameTimeMethod
Change from Baseline in Sex Risk Behavior Based on Number of Sex Partners and Condom Use at 12 months12 months
Change from Baseline in Sex Risk Behavior Based on Number of Sex Partners and Condom Use at 6 months6 months
Change from Baseline in Injection Risk Behavior Based on Sharing Needles, Cookers, and Cotton For Injection and Drug Splitting at 6 months6 months
Change from Baseline in Injection Risk Behavior Based on Sharing Needles, Cookers, and Cotton For Injection and Drug Splitting at 12 months12 months

Trial Locations

Locations (1)

Lighthouse Studies @ Peer Points- JHSPH

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath